By Adriano Marchese Biopharmaceutical company Quantum BioPharma said it has acquired 2,000 shares of specialty games and entertainment retailer GameStop in what it calls a strategic investment.

SOUTH SAN FRANCISCO, Calif., July 22, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), an oncology company pioneering site-specific and novel-format antibody ...

Aspire Biopharma Holdings, Inc. to Launch its BUZZ BOMB Pre-Workout Supplement at FitCon and FitExpo, Two of the Largest Fitness Conventions in the World Written by aspire biopharma holdings inc.

British biopharmaceutical company GlaxoSmithKline will lay off 150 employees in its Cambridge operations by the end of March 2026, the company said in a notice to the state. The company said ...

Vor Biopharma Inc. (NASDAQ:VOR) is one of the hot penny stocks to invest in now. In a report released on June 30, Swayampakula Ramakanth from H.C. Wainwright upgraded Vor Biopharma Inc.

Yet another biopharma name has been run through a familiar trading cycle that often ends on a bullish note.

Additional complete response (CR) observed in patient with multiple tumorsConfirmed overall response rate (ORR) of 50% in patients with combined positive score (CPS) ≥1, including 50% ORR in ...

Layoffs in biopharma show no signs of slowing, with workforce reductions holding steady across the first two quarters of 2025. | Biopharma layoffs have held steady through mid-2025, and in this ...

Biopharma layoff rounds reported this May hit an all-time high, with 29 reductions in force (RIFs) occurring—the most of any month reported over the last four years that Fierce Biotech has spent ...

ArriVent BioPharma aims to raise $75 million in a public stock sale, using the proceeds to advance its lung cancer drug and other pipeline programs.

Argon AI Inc., the developer of an artificial intelligence-native workspace platform purpose-built for life sciences, today announced it has raised $5.5 million in seed funding to bring insights ...

Proposed cuts will have “a catastrophic effect on the advancement of biomedical and biotechnology capabilities in the United States,” more than 100 leaders of biomedical/health sciences ...